U.S. Stem Cell, Inc. Annual Interest Paid, Excluding Capitalized Interest, Operating Activities in USD from 2017 to 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
U.S. Stem Cell, Inc. annual/quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from 2017 to 2022.
- U.S. Stem Cell, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending March 31, 2022 was $5.38K, a 31% decline year-over-year.
- U.S. Stem Cell, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $6.11K, a 73.1% decline from 2021.
- U.S. Stem Cell, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $22.8K, a 44.5% decline from 2020.
- U.S. Stem Cell, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2020 was $41K, a 94.8% decline from 2019.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Growth (%)